Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays

Transplantation

Volumn 98, Issue 6, 2014, Pages 625-631

  Visentin, Jonathan ^a,b   Vigata, Margaux ^a   Daburon, Sophie ^b   Contin Bordes, Cécile ^a,b   Fremeaux Bacchi, Véronique ^c   Dromer, Claire ^d   Billes, Marc Alain ^d   Neau Cransac, Martine ^a   Guidicelli, Gwendaline ^a   Taupin, Jean Luc ^a,b  

^a HÔPITAL PELLEGRIN   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Complement; HLA antibodies; Interference; Prozone phenomenon; Single antigen flow beads

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANTIBODY; AUTOANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3D ANTIBODY; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4D ANTIBODY; COMPLEMENT COMPONENT C5; EDETIC ACID; IMMUNOGLOBULIN G; LEUKOCYTE ANTIGEN ANTIBODY; UNCLASSIFIED DRUG; COMPLEMENT; COMPLEMENT C4D; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C4B; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; PEPTIDE FRAGMENT; PROTEIN BINDING;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; COMPLEMENT FIXATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; FLOW BEAD ASSAY; HUMAN; IMMUNOASSAY; MALE; PRIORITY JOURNAL; CHEMISTRY; DEFICIENCY; IMMUNE DEFICIENCY; IMMUNOLOGY; PROCEDURES;

ANTIBODIES, MONOCLONAL; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; COMPLEMENT C3; COMPLEMENT C3D; COMPLEMENT C4B; COMPLEMENT SYSTEM PROTEINS; EDETIC ACID; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; IMMUNOASSAY; IMMUNOLOGIC DEFICIENCY SYNDROMES; PEPTIDE FRAGMENTS; PROTEIN BINDING;

EID: 84922481130     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000315     Document Type: Article

References (15)

1. Heidelberger M, Kendall FE. A quantitative theory of the precipitin reaction: III. The reaction between crystalline egg albumin and its homologous antibody. J Exp Med 1935; 62: 697.
2. Selby C. Interference in immunoassay. Ann Clin Biochem 1999; 36(Pt 6): 704.
3. Schnaidt M, Weinstock C, Jurisic M, et al. HLA antibody specification using single-antigen beadsVa technical solution for the prozone effect. Transplantation 2011; 92: 510.
4. Guidicelli G, Anies G, Bachelet T, et al. The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients. Transpl Immunol 2013; 29: 17.
5. Weinstock C, SchnaidtM. The complement-mediated prozone effect in the Luminex single-antigen bead assay and its impact on HLA antibody determination in patient sera. Int J Immunogenet 2013; 40: 171.
6. Budayova-Spano M, LacroixM, ThielensNM, et al. The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex. EMBO J 2002; 21: 231.
7. DoddsAW,RenXD,WillisAC, et al. The reactionmechanismof the internal thioester in the human complement component C4. Nature. 1996; 379: 177.
8. Harboe M, Ulvund G, Vien L, et al. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin Exp Immunol 2004; 138: 439.
9. Schwaiger E, Wahrmann M, Bond G, et al. Complement component C3 activation: The leading cause of the prozone phenomenon affecting HLA antibody detection on single-antigen beads. Transplantation 2014; 97: 1279.
10. Wahrmann M, Exner M, Haidbauer B, et al. [C4d]FlowPRA screeningVa specific assay for selective detection of complementactivating anti-HLA alloantibodies. Hum Immunol 2005; 66: 526.
11. Smith JD, Hamour IM, Banner NR, et al. C4d fixing, luminex binding antibodiesVa new tool for prediction of graft failure after heart transplantation. Am J Transplant 2007; 7: 2809.
12. Wahrmann M, Bartel G, Exner M, et al. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients. Transpl Int 2009; 22: 982.
13. Lachmann N, Todorova K, Schulze H, et al. Systematic comparison of four cell- and Luminex-based methods for assessment of complementactivating HLA antibodies. Transplantation 2013; 95: 694.
14. Duncan AR,Winter G. The binding site for C1q on IgG. Nature 1988; 332: 738.
15. Diebolder CA, Beurskens FJ, de Jong RN, et al. Complement is activated by IgG hexamers assembled at the cell surface. Science 2014; 343: 1260.